Next |
home / stock / uncy / uncy message board
Subject | By | Source | When |
---|---|---|---|
Two sweet up days in a row! Keep | subslover | investorshub | 03/20/2023 5:41:25 PM |
Heading back up! | subslover | investorshub | 03/16/2023 4:10:52 PM |
Pullback today, theres alot of profit on the | harry crumb | investorshub | 03/13/2023 1:13:24 PM |
Based on its pipeline value, $1.5 is max. | Alan Brown | investorshub | 03/13/2023 6:22:47 AM |
$5.00 maybe ? | ddt60 | investorshub | 03/11/2023 5:49:33 PM |
Harry--------Is this high enough? tia | subslover | investorshub | 03/11/2023 4:56:39 PM |
Not high enough | harry crumb | investorshub | 03/11/2023 3:47:34 PM |
How high is the moon | Alan Brown | investorshub | 03/11/2023 4:25:53 AM |
znewcar1: $UNCY 30% v69,8M c2.68 f15,088M H2.87 Haft2.89 | znewcar1 | investorshangout | 03/10/2023 11:42:36 PM |
And with a new 52-week high! :) | subslover | investorshub | 03/10/2023 9:57:40 PM |
Nice end to the week. | ddt60 | investorshub | 03/10/2023 8:29:34 PM |
Looks like 3 White soldiers in the making! | Rite Angle$ | investorshub | 03/10/2023 5:17:28 PM |
Nice pre-market action! | subslover | investorshub | 03/10/2023 1:40:31 PM |
Nice pre-market action! | subslover | investorshub | 03/10/2023 1:40:30 PM |
The markets are crumpling an crashing an this | harry crumb | investorshub | 03/10/2023 1:14:47 PM |
This is going to the moon | harry crumb | investorshub | 03/10/2023 1:14:00 PM |
I think it can't | Alan Brown | investorshub | 03/10/2023 11:06:44 AM |
#$UNCY ?? can it touch $3-5 area? Showing | da_stock_analyst | investorshub | 03/10/2023 2:34:55 AM |
3 mil float. 5 mil more buys than | 1hot toddy | investorshub | 03/10/2023 1:54:37 AM |
znewcar1: $UNCY 27% v46,3M c2.06 f15,088M H2.24 ML.045 gapNhold1.5 | znewcar1 | investorshangout | 03/09/2023 11:20:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Unicycive Therapeutics Inc. Company Name:
UNCY Stock Symbol:
NASDAQ Market:
– Successfully Established Favorable Tolerability and Safety of OLC – – New Drug Application (NDA) Submission Anticipated in Q3 2024 – – Webcast and Conference Call Today at 8:30 A.M. ET – LOS ALTOS, Calif., June 25, 2024 (GLOBE NE...
– Results from Preclinical Model of Hyperphosphatemia Demonstrate the Relative Potency of OLC Compared to Tenapanor – – Oral UNI-494 Shows Promise in a Preclinical Model as a Potential Candidate for Prevention of Delayed Graft Function Related to Acute Kidney Injury...
LOS ALTOS, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Ex...